Abstract
Introduction: Proteomic biomarkers related to cardiovascular disease (CVD) risk factors may offer insights into the pathogenesis of subclinical and clinical CVD. Hypothesis: We hypothesized that 1) CVD risk factors may have distinctive proteomic signatures; and 2) select proteins are associated with multiple CVD risk factors indicating a central (pleiotropic) role in disease pathogenesis. Methods: We measured 1317 circulating plasma proteomic biomarkers (SomaScan; using the SomaLogic platform) in up to 897 Framingham Heart Study Generation 3 participants (mean age 46 years; 56% women) without hypertension, diabetes mellitus, or clinical CVD at the second examination (2008-2011). We used linear regression (or logistic for binary outcomes) to relate levels of each inverse-log transformed proteomic biomarker to age, sex, body mass index (BMI), waist circumference, systolic and diastolic blood pressure, blood lipid fractions, fasting blood sugar and insulin, coronary artery calcium (by computed tomography), left ventricular mass (by echocardiography), pre-hypertension, pre-diabetes, dyslipidemia, overweight, obesity, alcohol consumption, physical activity (by accelerometer), and smoking. All models adjusted for age, sex, and BMI. A Bonferroni-adjusted p-value <2.7E-5 indicated statistical significance. Results: Forty-one proteins were associated with ≥8 CVD risk factors and 13 proteins (Apo E, C5a, GHR, IGFBP-2, leptin, NG36, Notch-3, QORL1, RGMB, SHBG, TIG2, XTP3A, tPA) were associated with ≥10 risk factors. Illustrative volcano plots for proteomic signatures of smoking and physical activity show high representation of proteins related to tumor suppression, immunologic function, and cellular communication (Figure). Conclusions: Our cross-sectional data from a relatively healthy community-based sample elucidated distinctive proteomic signatures of CVD risk factors. A small group of proteins were associated with multiple risk factors, suggesting their potential pleiotropic role in CVD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.